Last Posted: Apr 28, 2019
- Genomic Medicine Meets Public Health in the Prevention of Cardiovascular Disease: Familial Hypercholesterolemia as a Paradigm
CDC Webinar, May 30, 2019 - VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
Miramontes-González José Pablo et al. Atherosclerosis 2019 Mar 28517-22 - Lay Perspectives on Receiving Different Types of Genomic Secondary Findings: a Qualitative Vignette Study.
Vornanen M et al. Journal of genetic counseling 2019 Apr 28(2) 343-354 - Finding missed cases of familial hypercholesterolemia in health systems using machine learning
Banda, JM, et al. npj Digital Medicine Volume 2, Article number: 23 (2019) - Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems.
Chen Peipei et al. Frontiers in physiology 2019 10280 - FIND FH® Effectively Identified Individuals with Possible Familial Hypercholesterolemia (FH) in Electronic Health Records
Cision PR Newswire, April 11, 2019 - A review of gene- and cell-based therapies for familial hypercholesterolemia.
Hajighasemi Saeideh et al. Pharmacological research 2019 Mar 143119-132 - Diagnosis of Familial Hypercholesterolaemia on First Sight? The Role of the Ophthalmologist in Identifying Patients with Familial Hypercholesterolaemia.
Altschmiedová T et al. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2019 74(4) 127-131 - How much further do we need to decrease LDL cholesterol levels in heterozygous familial hypercholesterolemia?
Harada-Shiba Mariko et al. Atherosclerosis 2019 Mar - Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.
Roberts Megan C et al. Ethnicity & disease 2019 29(Suppl 1) 187-192
.png)
No hay comentarios:
Publicar un comentario